Amratia P, Kerr-Jones L, Chapman L, Marsden M, Clement M, Stanton R
mBio. 2024; 15(8):e0315223.
PMID: 38953361
PMC: 11323495.
DOI: 10.1128/mbio.03152-23.
Yan Y, Tang Y, Zheng C
J Med Virol. 2022; 94(7):2962-2968.
PMID: 35288942
PMC: 9088476.
DOI: 10.1002/jmv.27719.
Schutz M, Steingruber M, Socher E, Muller R, Wagner S, Kogel M
Viruses. 2021; 13(7).
PMID: 34198986
PMC: 8310212.
DOI: 10.3390/v13071248.
Liao Y, Ke X, Deng T, Qin Q
Front Microbiol. 2021; 12:675112.
PMID: 34012430
PMC: 8126617.
DOI: 10.3389/fmicb.2021.675112.
Tessier T, Dodge M, Prusinkiewicz M, Mymryk J
Cells. 2019; 8(6).
PMID: 31181773
PMC: 6627039.
DOI: 10.3390/cells8060559.
In vitro toxicity and efficacy of verdinexor, an exportin 1 inhibitor, on opportunistic viruses affecting immunocompromised individuals.
Widman D, Gornisiewicz S, Shacham S, Tamir S
PLoS One. 2018; 13(10):e0200043.
PMID: 30332435
PMC: 6192554.
DOI: 10.1371/journal.pone.0200043.
CRM1 Inhibitors for Antiviral Therapy.
Mathew C, Ghildyal R
Front Microbiol. 2017; 8:1171.
PMID: 28702009
PMC: 5487384.
DOI: 10.3389/fmicb.2017.01171.
RO0504985 is an inhibitor of CMGC kinase proteins and has anti-human cytomegalovirus activity.
Strang B
Antiviral Res. 2017; 144:21-26.
PMID: 28501424
PMC: 9233920.
DOI: 10.1016/j.antiviral.2017.05.004.
Antiviral Efficacy of Verdinexor In Vivo in Two Animal Models of Influenza A Virus Infection.
Perwitasari O, Johnson S, Yan X, Register E, Crabtree J, Gabbard J
PLoS One. 2016; 11(11):e0167221.
PMID: 27893810
PMC: 5125695.
DOI: 10.1371/journal.pone.0167221.
The absence of p53 during Human Cytomegalovirus infection leads to decreased UL53 expression, disrupting UL50 localization to the inner nuclear membrane, and thereby inhibiting capsid nuclear egress.
Kuan M, ODowd J, Fortunato E
Virology. 2016; 497:262-278.
PMID: 27498409
PMC: 5026620.
DOI: 10.1016/j.virol.2016.07.020.
Verdinexor, a novel selective inhibitor of nuclear export, reduces influenza a virus replication in vitro and in vivo.
Perwitasari O, Johnson S, Yan X, Howerth E, Shacham S, Landesman Y
J Virol. 2014; 88(17):10228-43.
PMID: 24965445
PMC: 4136318.
DOI: 10.1128/JVI.01774-14.
Role of human cytomegalovirus tegument proteins in virion assembly.
Smith R, Kosuri S, Kerry J
Viruses. 2014; 6(2):582-605.
PMID: 24509811
PMC: 3939473.
DOI: 10.3390/v6020582.
Nucleocytoplasmic shuttling and CRM1-dependent MHC class I peptide presentation of human cytomegalovirus pp65.
Frankenberg N, Lischka P, Pepperl-Klindworth S, Stamminger T, Plachter B
Med Microbiol Immunol. 2012; 201(4):567-79.
PMID: 22965172
DOI: 10.1007/s00430-012-0269-7.
Human cytomegalovirus UL97 kinase alters the accumulation of CDK1.
Gill R, James S, Prichard M
J Gen Virol. 2012; 93(Pt 8):1743-1755.
PMID: 22552942
PMC: 3541764.
DOI: 10.1099/vir.0.039214-0.
Human cytomegalovirus tegument proteins (pp65, pp71, pp150, pp28).
Tomtishen 3rd J
Virol J. 2012; 9:22.
PMID: 22251420
PMC: 3278345.
DOI: 10.1186/1743-422X-9-22.
Sites and roles of phosphorylation of the human cytomegalovirus DNA polymerase subunit UL44.
Silva L, Strang B, Lin E, Kamil J, Coen D
Virology. 2011; 417(2):268-80.
PMID: 21784501
PMC: 3434964.
DOI: 10.1016/j.virol.2011.06.008.
Cyclin-dependent kinase activity controls the onset of the HCMV lytic cycle.
Zydek M, Hagemeier C, Wiebusch L
PLoS Pathog. 2010; 6(9):e1001096.
PMID: 20844576
PMC: 2936547.
DOI: 10.1371/journal.ppat.1001096.
Human cytomegaloviruses expressing yellow fluorescent fusion proteins--characterization and use in antiviral screening.
Straschewski S, Warmer M, Frascaroli G, Hohenberg H, Mertens T, Winkler M
PLoS One. 2010; 5(2):e9174.
PMID: 20161802
PMC: 2820100.
DOI: 10.1371/journal.pone.0009174.
Biologic and immunologic effects of knockout of human cytomegalovirus pp65 nuclear localization signal.
Zaia J, Li X, Franck A, Wu X, Thao L, Gallez-Hawkins G
Clin Vaccine Immunol. 2009; 16(6):935-43.
PMID: 19369477
PMC: 2691050.
DOI: 10.1128/CVI.00011-09.
Nuclear trafficking of the human cytomegalovirus pp71 (ppUL82) tegument protein.
Shen W, Westgard E, Huang L, Ward M, Osborn J, Chau N
Virology. 2008; 376(1):42-52.
PMID: 18423509
PMC: 2464290.
DOI: 10.1016/j.virol.2008.03.007.